ArticleLasers in medical science2025
5-Aminolevulinic acid-mediated photodynamic therapy improves scar healing of laryngeal wounds in rats.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
To evaluated the efficacy of photodynamic therapy (PDT) in improving laryngeal mucosal wound scar healing in vivo and investigated its underlying mechanisms. Laryngeal mucosal wounds were induced in Sprague-Dawley rats. Two weeks post-injury, PDT was administered via intraperitoneal injection of 100 mg/kg 5-aminolevulinic acid (5-ALA) and 635-nm red laser irradiation at varying energy doses (15, 30, and 45 J/cm²). The wounds' histological assessment was performed one month after two PDTs (one/week), including hematoxylin-eosin, Masson staining, Immunohistochemical staining for collagen I and III, and Alcian Blue staining for the detection of hyaluronic acid. In vitro, the viability of human skin fibroblasts (HFF-1) exposed to different light energy (0.3, 0.6, and 1.2 J/cm²) was assessed using CCK-8. Sublethal-dose PDT (SL-PDT; 5-ALA: 0.125 mmol/L, light: 0.6 J/cm²) was used in subsequent experiments. The effect of PDT on fibroblast differentiation into myofibroblasts was evaluated by measuring α-SMA expression in fibroblasts through RT-qPCR and Western blotting. Histological evaluation revealed that following PDT, the trauma site thickness increased, collagen density decreased, and hyaluronic acid deposition was elevated. Immunohistochemical analysis showed improved distribution of type I and type III collagen, coupled with a reduction in density. The most prominent change was observed in the 45 J/cm² PDT group. PDT had a dose-dependent effect on fibroblast viability, and significantly reduced fibroblast differentiation into myofibroblasts by upregulating urokinase plasminogen activator receptor (uPAR) protein expression in fibroblast. PDT can alleviate scar healing of laryngeal tissue wounds by suppressing excessive myofibroblast activation, effectively preserving laryngeal function.
Indexed as
Identifiers
40924290What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.